Literature DB >> 22594932

SIT: efficacy depends on product, not on route of application.

Claus Bachert, G Walter Canonica, Albrecht Bufe.   

Abstract

Mesh：

Year:  2012        PMID： 22594932     DOI： 10.1111/j.1399-3038.2012.01285.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN： 0905-6157            Impact factor:   6.377


× No keyword cloud information.
  4 in total

Review 1.  Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis.

Authors:  Ivana Đurić-Filipović; Marco Caminati; Gordana Kostić; Đorđe Filipović; Zorica Živković
Journal:  World J Pediatr       Date:  2016-06-29       Impact factor: 2.764

2.  Sublingual immunotherapy: World Allergy Organization position paper 2013 update.

Authors:  Giorgio Walter Canonica; Linda Cox; Ruby Pawankar; Carlos E Baena-Cagnani; Michael Blaiss; Sergio Bonini; Jean Bousquet; Moises Calderón; Enrico Compalati; Stephen R Durham; Roy Gerth van Wijk; Désirée Larenas-Linnemann; Harold Nelson; Giovanni Passalacqua; Oliver Pfaar; Nelson Rosário; Dermot Ryan; Lanny Rosenwasser; Peter Schmid-Grendelmeier; Gianenrico Senna; Erkka Valovirta; Hugo Van Bever; Pakit Vichyanond; Ulrich Wahn; Osman Yusuf
Journal:  World Allergy Organ J       Date:  2014-03-28       Impact factor: 4.084

Review 3.  Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report.

Authors:  Giovanni Battista Pajno; Roberto Bernardini; Diego Peroni; Stefania Arasi; Alberto Martelli; Massimo Landi; Giovanni Passalacqua; Antonella Muraro; Stefania La Grutta; Alessandro Fiocchi; Luciana Indinnimeo; Carlo Caffarelli; Elisabetta Calamelli; Pasquale Comberiati; Marzia Duse
Journal:  Ital J Pediatr       Date:  2017-01-23       Impact factor: 2.638

4.  Allergen immunotherapy on the way to product-based evaluation-a WAO statement.

Authors:  Claus Bachert; Mark Larché; Sergio Bonini; Giorgio Walter Canonica; Thomas Kündig; Desiree Larenas-Linnemann; Dennis Ledford; Hugo Neffen; Ruby Pawankar; Giovanni Passalacqua
Journal:  World Allergy Organ J       Date:  2015-09-16       Impact factor: 4.084
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.